cbdMD, Inc.
YCBD
$0.85
$0.011.59%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.19M | 19.03M | 19.59M | 19.22M | 19.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.19M | 19.03M | 19.59M | 19.22M | 19.48M |
| Cost of Revenue | 7.22M | 7.38M | 7.38M | 7.38M | 7.49M |
| Gross Profit | 11.97M | 11.64M | 12.22M | 11.84M | 12.00M |
| SG&A Expenses | 11.99M | 11.91M | 11.99M | 12.35M | 13.29M |
| Depreciation & Amortization | 1.13M | 1.15M | 1.16M | 1.16M | 1.15M |
| Other Operating Expenses | 978.80K | 332.50K | 300.30K | 627.90K | 835.70K |
| Total Operating Expenses | 21.35M | 20.82M | 20.86M | 21.56M | 22.80M |
| Operating Income | -2.16M | -1.79M | -1.27M | -2.34M | -3.32M |
| Income Before Tax | -2.04M | -1.51M | -158.80K | -2.69M | -3.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.04 | -1.51 | -0.16 | -2.69 | -3.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.04M | -1.51M | -158.80K | -2.69M | -3.70M |
| EBIT | -2.16M | -1.79M | -1.27M | -2.34M | -3.32M |
| EBITDA | -1.04M | -641.50K | -111.30K | -1.17M | -2.17M |
| EPS Basic | -3.92 | -5.05 | -6.04 | -14.98 | -18.64 |
| Normalized Basic EPS | -0.61 | -0.77 | -1.22 | -3.49 | -5.21 |
| EPS Diluted | -3.92 | -5.05 | -6.04 | -14.98 | -18.64 |
| Normalized Diluted EPS | -0.61 | -0.77 | -1.22 | -3.49 | -5.21 |
| Average Basic Shares Outstanding | 16.09M | 8.09M | 2.75M | 2.35M | 2.15M |
| Average Diluted Shares Outstanding | 16.09M | 8.09M | 2.75M | 2.35M | 2.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |